BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12833255)

  • 1. Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban.
    Lockwood NA; Tu RS; Zhang Z; Tirrell MV; Thomas DD; Karim CB
    Biopolymers; 2003 Jul; 69(3):283-92. PubMed ID: 12833255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic domains of phospholamban and phospholemman associate with phospholipid membrane surfaces.
    Clayton JC; Hughes E; Middleton DA
    Biochemistry; 2005 Dec; 44(51):17016-26. PubMed ID: 16363815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation by cAMP-dependent protein kinase modulates the structural coupling between the transmembrane and cytosolic domains of phospholamban.
    Li J; Bigelow DJ; Squier TC
    Biochemistry; 2003 Sep; 42(36):10674-82. PubMed ID: 12962492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and dynamics of phospholamban in solution and in membrane bilayer: computer simulations.
    Houndonougbo Y; Kuczera K; Jas GS
    Biochemistry; 2005 Feb; 44(6):1780-92. PubMed ID: 15697203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helical structure of phospholamban in membrane bilayers.
    Smith SO; Kawakami T; Liu W; Ziliox M; Aimoto S
    J Mol Biol; 2001 Nov; 313(5):1139-48. PubMed ID: 11700069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural model of the phospholamban ion channel complex in phospholipid membranes.
    Arkin IT; Rothman M; Ludlam CF; Aimoto S; Engelman DM; Rothschild KJ; Smith SO
    J Mol Biol; 1995 May; 248(4):824-34. PubMed ID: 7752243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholamban binds in a compact and ordered conformation to the Ca-ATPase.
    Li J; Xiong Y; Bigelow DJ; Squier TC
    Biochemistry; 2004 Jan; 43(2):455-63. PubMed ID: 14717600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes within the cytosolic portion of phospholamban upon release of Ca-ATPase inhibition.
    Li J; Bigelow DJ; Squier TC
    Biochemistry; 2004 Apr; 43(13):3870-9. PubMed ID: 15049694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron paramagnetic resonance reveals a large-scale conformational change in the cytoplasmic domain of phospholamban upon binding to the sarcoplasmic reticulum Ca-ATPase.
    Kirby TL; Karim CB; Thomas DD
    Biochemistry; 2004 May; 43(19):5842-52. PubMed ID: 15134458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.
    Paterlini MG; Thomas DD
    Biophys J; 2005 May; 88(5):3243-51. PubMed ID: 15764655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump.
    Afara MR; Trieber CA; Ceholski DK; Young HS
    Biochemistry; 2008 Sep; 47(36):9522-30. PubMed ID: 18702513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depolymerization of phospholamban in the presence of calcium pump: a fluorescence energy transfer study.
    Reddy LG; Jones LR; Thomas DD
    Biochemistry; 1999 Mar; 38(13):3954-62. PubMed ID: 10194307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase.
    Karim CB; Marquardt CG; Stamm JD; Barany G; Thomas DD
    Biochemistry; 2000 Sep; 39(35):10892-7. PubMed ID: 10978176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the dynamic properties of the transmembrane segment of phospholamban incorporated into phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy.
    Tiburu EK; Karp ES; Dave PC; Damodaran K; Lorigan GA
    Biochemistry; 2004 Nov; 43(44):13899-909. PubMed ID: 15518538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation-induced structural change in phospholamban and its mutants, detected by intrinsic fluorescence.
    Li M; Cornea RL; Autry JM; Jones LR; Thomas DD
    Biochemistry; 1998 May; 37(21):7869-77. PubMed ID: 9601048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray structure of a water-soluble analog of the membrane protein phospholamban: sequence determinants defining the topology of tetrameric and pentameric coiled coils.
    Slovic AM; Stayrook SE; North B; Degrado WF
    J Mol Biol; 2005 May; 348(3):777-87. PubMed ID: 15826670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation energy for insertion of transmembrane alpha-helices is dependent on membrane composition.
    Meijberg W; Booth PJ
    J Mol Biol; 2002 Jun; 319(3):839-53. PubMed ID: 12054874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CMAP and electrostatic cutoffs on the dynamics of an integral membrane protein: the phospholamban study.
    Houndonougbo Y; Kuczera K; Jas GS
    J Biomol Struct Dyn; 2008 Aug; 26(1):17-34. PubMed ID: 18533723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A solid-state NMR study of the phospholamban transmembrane domain: local structure and interactions with Ca(2+)-ATPase.
    Ahmed Z; Reid DG; Watts A; Middleton DA
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):187-98. PubMed ID: 11018663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the oligomeric state of phospholamban variants in phospholipid bilayers from solid-state NMR measurements of rotational diffusion rates.
    Hughes E; Clayton JC; Middleton DA
    Biochemistry; 2005 Mar; 44(10):4055-66. PubMed ID: 15751982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.